by Sia | Jun 20, 2024 | News
PoET® CMV is the first IVD assay on the market to screen donated blood for CMV by nucleic acid amplification technology (NAT) under the IVDR. Screening blood donors with the PoET® CMV test enables pathogen detection and reduces the risk of...
by Sia | Sep 13, 2023 | Events, News
We are glad to announce that GFE will attend 34th Regional Congress of the ISBT in Cape Town which will take place November 18 – 21, 2023. We are looking forward to your visit at our booth B78. All Information on...
by Sia | Sep 13, 2023 | Events, News
GFE will be participating in 56. Jahrestagung der DGTI from 20. – 22. September 2023 in Berlin. Come and meet our representatives at our Booth No. 14 in the exhibition area to learn more about our PoET® System. More Information can be found: here...
by Sia | May 18, 2022 | News
A new level of efficiency for WNV screening Frankfurt/Main – GFE today announced the launch of its PoET® WNV PCR kit. PoET® WNV is a CE-IVD marked test, based on real-time PCR technology, for the detection of West Nile virus RNA in human plasma samples. PoET® WNV is...
by Sia | Mar 31, 2021 | News
Frankfurt/Main – GFE today unveiled its vision for the future of NAT testing in blood screening, the PoET® system. A fully automated instrument, sophisticated software and a series of NAT tests make up this powerful solution for blood screening laboratories. Out of...
by Ralf Bartl | Mar 12, 2021 | News
Frankfurt am Main; Crailsheim, March 12, 2021. – GFE and LVL Technologies today announced to strengthening their long cooperation for the current sales and support of PCL’s COVID-19 antigen rapid test, whereas both companies combine their specific core competences to...
